| Literature DB >> 3477318 |
M H Robinson1, A C Jones, K D Durrant.
Abstract
The value of scalp cooling in the prevention of alopecia was investigated in 32 patients with advanced breast cancer who were given a mean of four courses of 40-80 mg/m2 of epirubicin. None of the 15 patients free from liver metastases who received scalp cooling required a wig, whereas four of eight similar patients who did not receive scalp cooling did require a wig. Abnormalities of aspartate transaminase and alkaline phosphatase pretreatment were predictive for reduced efficacy of scalp cooling, but not a contraindication to its use.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3477318
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960